Its not recommended for neonates, and shouldnt be used in epidural injections unless clearly stated by the manufacturer
According to clinical trials, prescription GLP-1 medications typically lead to 518% weight loss, while studies of high-dose tirzepatide combined with intensive lifestyle support have reported reductions of up to ~25%
These effects are independent of insulin but correlate with the recovery of the animals' white adipose tissue (Gunawardana and Piston, 2012)
GLP1-R is a class B G protein-coupled receptor, 25 and its expression has been reported in the cerebral cortex, especially the occipital and frontal lobes, hypothalamus, and thalamus, whereas lower levels are found in the caudate putamen, globus pallidus, and hippocampus